New antibody shows promise in reducing tau proteins associated with Alzheimer’s disease

A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer’s disease.

Cresco Labs Q3 Revenue Declines Less Than Expected

Cresco Labs Reports Third Quarter 2023 Financial Results Continued execution of Year-of-the-Core strategy delivers strong margin and operating cash flow gains, with elimination of over

November 15, 2023

GSK looks to authorized generic version of asthma treatment as Medicaid rebate caps lift next year

GSK is gearing up to discontinue the brand-name version of its asthma medication Flovent, just as the Medicaid rebate cap is ending in January 2024,

October 13, 2023

Australia sees a decline in type 2 diabetes, but disparities persist

Type 2 diabetes incidence in Australia decreased from 2010 to 2019 overall but rose among younger men and specific ethnic groups, highlighting persistent disparities.

January 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.